Association of CD14 and macrophage migration inhibitory factor gene polymorphisms with inflammatory microRNAs expression levels in ankylosing spondylitis and polyarthralgia. (4th June 2018)

• Record Type: Journal Article
• Authors: Vishwakarma, S. K.; Lakkireddy, C.; Sravani, G.; Sastry, B. V. S.; Raju, N.; Ahmed, S. I.; Khan, A. A.; Owaisi, N.; Jaisawal, A.; Khan, M. A.; Khan, A. A.
• Is Part Of: International journal of immunogenetics. Volume 45:Number 4(2018:Aug.)
• Page Start: 190
• Page End: 200
• Publication Date: 2018-06-04
• Subjects: ankylosing spondylitis -- CD14 and MIF gene polymorphism -- miRNA expression -- Polyarthralgia; Immunogenetics -- Periodicals; 571.9648
• DOI: 10.1111/iji.12366
• Languages: English
• ISSNs: 1744-3121

Abstract

Summary: This study aimed to investigate the genetic basis of ankylosing spondylitis (AS) and polyarthralgia (PA) conditions among Indian subjects through genotyping two immune regulatory genes CD14 (−159C>T) and MIF (−173G>C) and find their association with the expression levels of three circulating inflammatory miRNAs. This investigation may provide early genetic cause of these two forms of arthritis and more optimal biological targets to predict early therapeutic outcomes. A total of 140 patients (AS: 70 and PA: 70) and 156 controls were recruited from Indian population. CD14 and MIF genotyping was performed using ARMS–PCR. Expression level of three inflammatory miRNAs (miRNA‐146a, miRNA‐155 and miRNA‐181) was quantified using RT–qPCR. C/T genotype of CD14 gene was found to cause 2.06‐fold risk of developing AS (CI 1.06–5.98, p = .04) as compared to others and G/C genotype in MIF also shown significant variation between AS and control subjects. In PA subjects, CD14 genotypes (C/T) was found to be associated with disease susceptibility and G/C genotype of MIF gene polymorphism showed 4.71‐fold risk of developing PA (CI 2.58–8.62, p = .0001). The study also revealed significant upregulation of miRNA‐155 expression in AS subjects ( p = .0001) with more than 1.3‐fold difference between AS and PA as compared to the control subjects. miRNA‐155 had strong association with AS patients with CD14 genotypes ( p < .05) than PA and control subjects. This study provides better understanding of the mechanisms and disease susceptibility for MIF and CD14 genetic variants and inflammatory miRNAs networks involved in AS and PA.